In 2025, polydeoxyribonucleotide (PDRN) has rapidly emerged as one of the most closely watched bioactive materials in the global skincare and medical aesthetics industry. Across international ingredient exhibitions, functional skincare summits, and social media trend lists, PDRN has become an unavoidable keyword for brands, clinicians, and regulators alike. This momentum reflects not only growing scientific […]

The post PDRN Injectable Devices for NMPA Registration: Regulatory Pathways and a Case Study appeared first on China Med Device.

​